[3H]-lifarizine, a high affinity probe for inactivated sodium channels

Area of Science:

• Neuroscience
• Pharmacology
• Biochemistry

Background:

• Neuronal sodium channels are critical for action potential propagation.
• Understanding the subtypes and functional states of sodium channels is essential for developing targeted therapeutics.
• Lifarizine is a compound with potential interactions with sodium channels.

Purpose of the Study:

• To characterize the binding properties of [3H]-lifarizine to neuronal sodium channels.
• To determine the specific binding site and functional state of sodium channels targeted by lifarizine.
• To validate [3H]-lifarizine as a selective radioligand for inactivated sodium channels.

Main Methods:

• Radioligand binding assays using [3H]-lifarizine on rat cerebrocortical membranes and synaptosomes.
• Competition binding studies with known sodium channel toxins (tetrodotoxin, alpha-scorpion venom, brevetoxin, batrachotoxinin-A 20-alpha-benzoate).
• Voltage-clamp studies in NIE-115 neuroblastoma cells to correlate binding affinities with functional states.

Main Results:

• [3H]-lifarizine binds with high affinity (Kd = 10.7 nM) to a homogeneous population of sites in rat brain membranes.
• Lifarizine binding is voltage-sensitive and shows increased affinity upon depolarization, indicating selective binding to inactivated sodium channels.
• Lifarizine allosterically interacts with toxin binding site 2, distinct from sites for tetrodotoxin and scorpion venom.
• Binding affinities of compounds displacing [3H]-lifarizine strongly correlate with their affinities for inactivated sodium channels.

Conclusions:

• [3H]-lifarizine is a potent and selective radioligand for inactivated neuronal sodium channels.
• The binding site is allosterically linked to toxin binding site 2.
• [3H]-lifarizine serves as a valuable tool for investigating the pharmacology and function of inactivated sodium channels.